Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polkinghorne, K. R.
Right arrow Articles by Kerr, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polkinghorne, K. R.
Right arrow Articles by Kerr, P. G.
J Am Soc Nephrol 15:477-486, 2004
© 2004 American Society of Nephrology


CLINICAL SCIENCE

Vascular Access and All-Cause Mortality: A Propensity Score Analysis

Kevan R. Polkinghorne*, Stephen P. McDonald{dagger}, Robert C. Atkins* and Peter G. Kerr*,{dagger}

*Department of Nephrology, Monash Medical Centre, Melbourne, Victoria, and {dagger}ANZDATA Registry, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia

Correspondence to: Dr. K. R. Polkinghorne, Department of Nephrology, Monash Medical Centre, 246 Clayton Rd., Clayton, Melbourne, Victoria 3168, Australia. Phone: 61-3-95943529; Fax: 61-3-95946530; E-mail: kevan.polkinghorne{at}med.monash.edu.au

ABSTRACT. The native arteriovenous fistula (AVF) is the preferred vascular access because of its longevity and its lower rates of infection and intervention. Recent studies suggest that the AVF may offer a survival advantage. Because these data were derived from observational studies, they are prone to potential bias. The use of propensity scores offers an additional method to reduce bias resulting from nonrandomized treatment assignment. Adult (age 18 yr or more) patients who commenced hemodialysis in Australia and New Zealand on April 1, 1999, until March 31, 2002, were studied by using the Australian and New Zealand Dialysis and Transplant Association (ANZDATA) Registry. Cox regression was used to determine the effect of access type on total mortality. Propensity scores were calculated and used both as a controlling variable in the multivariable model and to construct matched cohorts. The catheter analysis was stratified by dialysis duration at entry to ANZDATA to satisfy the proportional-hazard assumption. There were 612 deaths in 3749 patients (median follow-up, 1.07 yr). After adjustment for confounding factors and propensity scores, catheter use was predictive of mortality. Patients with arteriovenous grafts (AVG) also had a significantly increased risk of death. Effect estimates were also consistent in the smaller propensity score–matched cohorts. Both AVG and catheter use in incident hemodialysis patients are associated with significant excess of total mortality. Reducing catheter use and increasing the proportion of patients commencing hemodialysis with a mature AVF remain important clinical objectives.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
S. P. McDonald, M. R. Marshall, D. W. Johnson, and K. R. Polkinghorne
Relationship between Dialysis Modality and Mortality
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 155 - 163.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Graham, S. Hiremath, P. O. Magner, G. A. Knoll, and K. D. Burns
Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3585 - 3591.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
L. M. Moist, L. Trpeski, Y. Na, and C. E. Lok
Increased Hemodialysis Catheter Use in Canada and Associated Mortality Risk: Data from the Canadian Organ Replacement Registry 2001-2004
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1726 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
T. Lobbedez, A. Lecouf, M. Ficheux, P. Henri, B. H. de Ligny, and J.-P. Ryckelynck
Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3290 - 3294.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Ethier, D. C. Mendelssohn, S. J. Elder, T. Hasegawa, T. Akizawa, T. Akiba, B. J. Canaud, and R. L. Pisoni
Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study
Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3219 - 3226.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. G. Craig and J. M. Hunter
Recent developments in the perioperative management of adult patients with chronic kidney disease
Br. J. Anaesth., September 1, 2008; 101(3): 296 - 310.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. Tonelli
Randomized Trials in Hemodialysis Patients: Time to Step Up to the Plate
JAMA, May 14, 2008; 299(18): 2205 - 2207.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. T. James, J. Conley, M. Tonelli, B. J. Manns, J. MacRae, B. R. Hemmelgarn, and for the Alberta Kidney Disease Network
Meta-analysis: Antibiotics for Prophylaxis against Hemodialysis Catheter-Related Infections
Ann Intern Med, April 15, 2008; 148(8): 596 - 605.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Al-Ghonaim, B. J. Manns, D. J. Hirsch, Z. Gao, M. Tonelli, and for the Alberta Kidney Disease Network
Relation between Access Blood Flow and Mortality in Chronic Hemodialysis Patients
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 387 - 391.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
C. E. Lok
Fistula First Initiative: Advantages and Pitfalls
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 1043 - 1053.
[Full Text] [PDF]


Home page
CJASNHome page
H. Wasse, N. Kutner, R. Zhang, and Y. Huang
Association of Initial Hemodialysis Vascular Access with Patient-Reported Health Status and Quality of Life
Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 708 - 714.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
D. Schon, S. W. Blume, K. Niebauer, C. S. Hollenbeak, and G. de Lissovoy
Increasing the Use of Arteriovenous Fistula in Hemodialysis: Economic Benefits and Economic Barriers
Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 268 - 276.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. W. I. Clark, R. A. Cohen, A. Kwak, J. F. Markmann, S. W. Stavropoulos, A. A. Patel, M. C. Soulen, J. I. Mondschein, S. Kobrin, R. D. Shlansky-Goldberg, et al.
Salvage of Nonmaturing Native Fistulas by Using Angioplasty
Radiology, December 1, 2006; 242(1): 286 - 292.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
L. Brenner, A. K. Singh, D. Campbell, F. Frei, and W. C. Winkelmayer
Associations between Demographic Factors and Provider Structures on Cost and Length of Stay for Hemodialysis Patients with Vascular Access Failure
Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 455 - 461.
[Abstract] [Full Text] [PDF]


Home page
Int J Qual Health CareHome page
J. E. Owen, R. J. Walker, L. Edgell, J. Collie, L. Douglas, T. D. Hewitson, and G. J. Becker
Implementation of a pre-dialysis clinical pathway for patients with chronic kidney disease
Int. J. Qual. Health Care, April 1, 2006; 18(2): 145 - 151.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. C. Mendelssohn, J. Ethier, S. J. Elder, R. Saran, F. K. Port, and R. L. Pisoni
Haemodialysis vascular access problems in Canada: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS II)
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton
CHAPTER 4: Vascular Access
J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S16 - S23.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. C. Astor, J. A. Eustace, N. R. Powe, M. J. Klag, N. E. Fink, J. Coresh, and for the CHOICE Study
Type of Vascular Access and Survival among Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1449 - 1455.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. W. Johnson, C. van Eps, D. W. Mudge, K. J. Wiggins, K. Armstrong, C. M. Hawley, S. B. Campbell, N. M. Isbel, G. R. Nimmo, and H. Gibbs
Randomized, Controlled Trial of Topical Exit-Site Application of Honey (Medihoney) versus Mupirocin for the Prevention of Catheter-Associated Infections in Hemodialysis Patients
J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1456 - 1462.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP